Practical Application of Immuno-Oncology in Renal Cell Carcinoma

Download All
In this online program based on a dynamic CCO symposium from the 2020 ASCO GU symposium, experts discuss the use of immunotherapy in treating patients with RCC. Use the updated irAE decision support tool and download the slides now.
Elizabeth R. Plimack, MD, MS
Program Director
Brian A. Costello, MD, MS
M. Dror Michaelson, MD, PhD
Martin H. Voss, MD

Downloadable Slidesets

Download this slideset from M. Dror Michaelson, MD, PhD, on his perspective for the optimal use of systemic therapy in the first-line setting for favorable-risk patients with advanced RCC.

Brian A. Costello, MD, MS M. Dror Michaelson, MD, PhD Released: February 13, 2020

Download this slideset from Martin H. Voss, MD, to learn more about selecting optimal first-line therapy for intermediate-risk/poor-risk patients with advanced RCC.

Martin H. Voss, MD Released: February 13, 2020

Download this slideset from Elizabeth R. Plimack, MD, MS, to see the latest data on treatment options for advanced RCC after previous therapy as well as how to manage AEs associated with RCC therapy.

Elizabeth R. Plimack, MD, MS
Program Director
Released: February 13, 2020
Provided by the National Comprehensive Cancer Network in partnership with Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

NCCN Logo
Supported by educational grants from
Eisai
Pfizer and EMD Serono

Supported by a medical education grant from
Exelixis, Inc.
Supported by an independent educational grant from
Merck & Co., Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings